Topcoin - I read the PubMed article and looked at Table 5 of our somascan CKD and noticed a number of changes. What should it mean to me? Please help me out, I seem to be riding the short bus today. It will be interesting to see in the full data reveal if they show the difference from the start of the BETonMACE trial to the end of the trial for these exact parameters for all of the CKD patients and then break it down between dosed and placebo. Honestly for me looking at the somascan it looked like the results for thrombosis could be staggering.

tada